133 related articles for article (PubMed ID: 21844033)
1. Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy.
Mehta SA; Ahmed A; Laverty M; Holzman RS; Valentine F; Sivapalasingam S
Clin Infect Dis; 2011 Sep; 53(5):490-6. PubMed ID: 21844033
[TBL] [Abstract][Full Text] [Related]
2. Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, Kenya.
Mehta SA; Ahmed A; Kariuki BW; Said S; Omasete F; Mendillo M; Laverty M; Holzman R; Valentine F; Sivapalasingam S
Am J Trop Med Hyg; 2010 Sep; 83(3):565-70. PubMed ID: 20810821
[TBL] [Abstract][Full Text] [Related]
3. Peripheral neuropathy in patients with human immunodeficiency viral infection at a tertiary hospital in Ghana.
Puplampu P; Ganu V; Kenu E; Kudzi W; Adjei P; Grize L; Käser M
J Neurovirol; 2019 Aug; 25(4):464-474. PubMed ID: 31028691
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
Evans D; Takuva S; Rassool M; Firnhaber C; Maskew M
J Neurovirol; 2012 Jun; 18(3):162-71. PubMed ID: 22528477
[TBL] [Abstract][Full Text] [Related]
5. Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya.
McGrath CJ; Njoroge J; John-Stewart GC; Kohler PK; Benki-Nugent SF; Thiga JW; Etyang A; Chung MH
J Neurovirol; 2012 Jun; 18(3):200-4. PubMed ID: 22528481
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
[TBL] [Abstract][Full Text] [Related]
7. Patterns of peripheral neuropathy in ART-naïve patients initiating modern ART regimen.
Lee AJ; Bosch RJ; Evans SR; Wu K; Harrison T; Grant P; Clifford DB
J Neurovirol; 2015 Apr; 21(2):210-8. PubMed ID: 25678143
[TBL] [Abstract][Full Text] [Related]
8. The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial.
Arenas-Pinto A; Bhaskaran K; Dunn D; Weller IV
Antivir Ther; 2008; 13(2):289-95. PubMed ID: 18505180
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
[TBL] [Abstract][Full Text] [Related]
10. Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South Africa.
Pahuja M; Grobler A; Glesby MJ; Karim F; Parker G; Gumede S; Naidoo K
Antivir Ther; 2012; 17(4):737-43. PubMed ID: 22414588
[TBL] [Abstract][Full Text] [Related]
11. HIV neuropathy in pre-HAART patients and it's correlation with risk factors in Central India.
Dubey TN; Raghuvanshi SS; Sharma H; Saxena R
Neurol India; 2013; 61(5):478-80. PubMed ID: 24262448
[TBL] [Abstract][Full Text] [Related]
12. Clinical diagnosis of sensory neuropathy in HIV patients treated with tenofovir: A 6-month follow-up study.
Pillay P; Wadley AL; Cherry CL; Karstaedt AS; Kamerman PR
J Peripher Nerv Syst; 2019 Dec; 24(4):304-313. PubMed ID: 31587421
[TBL] [Abstract][Full Text] [Related]
13. Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women.
Dao CN; Peters PJ; Kiarie JN; Zulu I; Muiruri P; Ong'ech J; Mutsotso W; Potter D; Njobvu L; Stringer JS; Borkowf CB; Bolu O; Weidle PJ
AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1149-55. PubMed ID: 21417949
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
[TBL] [Abstract][Full Text] [Related]
15. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
Silverman RA; John-Stewart GC; Beck IA; Milne R; Kiptinness C; McGrath CJ; Richardson BA; Chohan B; Sakr SR; Frenkel LM; Chung MH
PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992
[TBL] [Abstract][Full Text] [Related]
16. Peripheral neuropathy in ART-experienced patients: prevalence and risk factors.
Chen H; Clifford DB; Deng L; Wu K; Lee AJ; Bosch RJ; Riddler SA; Ellis RJ; Evans SR
J Neurovirol; 2013 Dec; 19(6):557-64. PubMed ID: 24297499
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of peripheral neuropathy and its associated demographic and health status characteristics, among people on antiretroviral therapy in Rwanda.
Tumusiime DK; Venter F; Musenge E; Stewart A
BMC Public Health; 2014 Dec; 14():1306. PubMed ID: 25526665
[TBL] [Abstract][Full Text] [Related]
18. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.
Geng EH; Hunt PW; Diero LO; Kimaiyo S; Somi GR; Okong P; Bangsberg DR; Bwana MB; Cohen CR; Otieno JA; Wabwire D; Elul B; Nash D; Easterbrook PJ; Braitstein P; Musick BS; Martin JN; Yiannoutsos CT; Wools-Kaloustian K
J Int AIDS Soc; 2011 Sep; 14():46. PubMed ID: 21955541
[TBL] [Abstract][Full Text] [Related]
19. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
Reid A; Stöhr W; Walker AS; Williams IG; Kityo C; Hughes P; Kambugu A; Gilks CF; Mugyenyi P; Munderi P; Hakim J; Gibb DM;
Clin Infect Dis; 2008 Apr; 46(8):1271-81. PubMed ID: 18444867
[TBL] [Abstract][Full Text] [Related]
20. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
